Infinium Pharmachem
Brands Companies Health News

Infinium Pharmachem Records Net Profit of Rs. 9.49 Cr In FY23, Growth Of 55.4 % Y-o-Y

Infinium Pharmachem , engaged in the manufacturing of Pharma Intermediates and APIs, Iodine derivatives has reported net profit of Rs. 9.49 crore for FY23, with Y-o-Y growth of 55.4% as compared to the net profit of Rs. 6.10 crore in FY22. Revenue from Operations grew 15.24% to Rs. 114.22 crore in FY23 as against revenue […]

Read More